Selected research
Industry Research
Chicken Medicine and Vaccines Industry Research Report 2026
Market perspective
The global Chicken Medicine and Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Chicken Medicine and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Chicken Medicine and Vaccines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Chicken Medicine and Vaccines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Chicken Medicine and Vaccines include CAVAC, CEVA, DHN, Elanco (Lohmann), FATRO, Merial, QYH Biotech, Ringpu Biology and Vaksindo, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Chicken Medicine and Vaccines market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Chicken Medicine and Vaccines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chicken Medicine and Vaccines Market by Company
CAVAC
CEVA
DHN
Elanco (Lohmann)
FATRO
Merial
QYH Biotech
Ringpu Biology
Vaksindo
Yebio
Zoetis
ChengDu Tecbond
Merck Animal Health
Harbin Veterinary Research Institute
Chicken Medicine and Vaccines Segment by Type
Medicine
Vaccines
Chicken Medicine and Vaccines Segment by Application
Farm
Government
Chicken Medicine and Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chicken Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chicken Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chicken Medicine and Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Chicken Medicine and Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medicine
- Vaccines
Applications
- Farm
- Government
Companies covered
- CAVAC
- CEVA
- DHN
- Elanco (Lohmann)
- FATRO
- Merial
- QYH Biotech
- Ringpu Biology
- Vaksindo
- Yebio
- Zoetis
- ChengDu Tecbond
- Merck Animal Health
- Harbin Veterinary Research Institute
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Chicken Medicine and Vaccines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Medicine
- 2.2.3 Vaccines
- 2.3 Chicken Medicine and Vaccines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Farm
- 2.3.3 Government
- 2.4 Assumptions and Limitations
3 Chicken Medicine and Vaccines Breakdown Data by Type
- 3.1 Global Chicken Medicine and Vaccines Historic Market Size by Type (2021-2026)
- 3.2 Global Chicken Medicine and Vaccines Forecasted Market Size by Type (2027-2032)
4 Chicken Medicine and Vaccines Breakdown Data by Application
- 4.1 Global Chicken Medicine and Vaccines Historic Market Size by Application (2021-2026)
- 4.2 Global Chicken Medicine and Vaccines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Chicken Medicine and Vaccines Market Perspective (2021-2032)
- 5.2 Global Chicken Medicine and Vaccines Growth Trends by Region
- 5.2.1 Global Chicken Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Chicken Medicine and Vaccines Historic Market Size by Region (2021-2026)
- 5.2.3 Chicken Medicine and Vaccines Forecasted Market Size by Region (2027-2032)
- 5.3 Chicken Medicine and Vaccines Market Dynamics
- 5.3.1 Chicken Medicine and Vaccines Industry Trends
- 5.3.2 Chicken Medicine and Vaccines Market Drivers
- 5.3.3 Chicken Medicine and Vaccines Market Challenges
- 5.3.4 Chicken Medicine and Vaccines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Chicken Medicine and Vaccines Players by Revenue
- 6.1.1 Global Top Chicken Medicine and Vaccines Players by Revenue (2021-2026)
- 6.1.2 Global Chicken Medicine and Vaccines Revenue Market Share by Players (2021-2026)
- 6.2 Global Chicken Medicine and Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Chicken Medicine and Vaccines Head Office and Area Served
- 6.4 Global Chicken Medicine and Vaccines Players, Product Type & Application
- 6.5 Global Chicken Medicine and Vaccines Manufacturers Established Date
- 6.6 Global Chicken Medicine and Vaccines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Chicken Medicine and Vaccines Market Size (2021-2032)
- 7.2 North America Chicken Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Chicken Medicine and Vaccines Market Size by Country (2021-2026)
- 7.4 North America Chicken Medicine and Vaccines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Chicken Medicine and Vaccines Market Size (2021-2032)
- 8.2 Europe Chicken Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Chicken Medicine and Vaccines Market Size by Country (2021-2026)
- 8.4 Europe Chicken Medicine and Vaccines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Chicken Medicine and Vaccines Market Size (2021-2032)
- 9.2 Asia-Pacific Chicken Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Chicken Medicine and Vaccines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Chicken Medicine and Vaccines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Chicken Medicine and Vaccines Market Size (2021-2032)
- 10.2 South America Chicken Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Chicken Medicine and Vaccines Market Size by Country (2021-2026)
- 10.4 South America Chicken Medicine and Vaccines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Chicken Medicine and Vaccines Market Size (2021-2032)
- 11.2 Middle East & Africa Chicken Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Chicken Medicine and Vaccines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Chicken Medicine and Vaccines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CAVAC
- 12.1.1 CAVAC Company Information
- 12.1.2 CAVAC Business Overview
- 12.1.3 CAVAC Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.1.4 CAVAC Chicken Medicine and Vaccines Product Portfolio
- 12.1.5 CAVAC Recent Developments
- 12.2 CEVA
- 12.2.1 CEVA Company Information
- 12.2.2 CEVA Business Overview
- 12.2.3 CEVA Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.2.4 CEVA Chicken Medicine and Vaccines Product Portfolio
- 12.2.5 CEVA Recent Developments
- 12.3 DHN
- 12.3.1 DHN Company Information
- 12.3.2 DHN Business Overview
- 12.3.3 DHN Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.3.4 DHN Chicken Medicine and Vaccines Product Portfolio
- 12.3.5 DHN Recent Developments
- 12.4 Elanco (Lohmann)
- 12.4.1 Elanco (Lohmann) Company Information
- 12.4.2 Elanco (Lohmann) Business Overview
- 12.4.3 Elanco (Lohmann) Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.4.4 Elanco (Lohmann) Chicken Medicine and Vaccines Product Portfolio
- 12.4.5 Elanco (Lohmann) Recent Developments
- 12.5 FATRO
- 12.5.1 FATRO Company Information
- 12.5.2 FATRO Business Overview
- 12.5.3 FATRO Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.5.4 FATRO Chicken Medicine and Vaccines Product Portfolio
- 12.5.5 FATRO Recent Developments
- 12.6 Merial
- 12.6.1 Merial Company Information
- 12.6.2 Merial Business Overview
- 12.6.3 Merial Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.6.4 Merial Chicken Medicine and Vaccines Product Portfolio
- 12.6.5 Merial Recent Developments
- 12.7 QYH Biotech
- 12.7.1 QYH Biotech Company Information
- 12.7.2 QYH Biotech Business Overview
- 12.7.3 QYH Biotech Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.7.4 QYH Biotech Chicken Medicine and Vaccines Product Portfolio
- 12.7.5 QYH Biotech Recent Developments
- 12.8 Ringpu Biology
- 12.8.1 Ringpu Biology Company Information
- 12.8.2 Ringpu Biology Business Overview
- 12.8.3 Ringpu Biology Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.8.4 Ringpu Biology Chicken Medicine and Vaccines Product Portfolio
- 12.8.5 Ringpu Biology Recent Developments
- 12.9 Vaksindo
- 12.9.1 Vaksindo Company Information
- 12.9.2 Vaksindo Business Overview
- 12.9.3 Vaksindo Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.9.4 Vaksindo Chicken Medicine and Vaccines Product Portfolio
- 12.9.5 Vaksindo Recent Developments
- 12.10 Yebio
- 12.10.1 Yebio Company Information
- 12.10.2 Yebio Business Overview
- 12.10.3 Yebio Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.10.4 Yebio Chicken Medicine and Vaccines Product Portfolio
- 12.10.5 Yebio Recent Developments
- 12.11 Zoetis
- 12.11.1 Zoetis Company Information
- 12.11.2 Zoetis Business Overview
- 12.11.3 Zoetis Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.11.4 Zoetis Chicken Medicine and Vaccines Product Portfolio
- 12.11.5 Zoetis Recent Developments
- 12.12 ChengDu Tecbond
- 12.12.1 ChengDu Tecbond Company Information
- 12.12.2 ChengDu Tecbond Business Overview
- 12.12.3 ChengDu Tecbond Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.12.4 ChengDu Tecbond Chicken Medicine and Vaccines Product Portfolio
- 12.12.5 ChengDu Tecbond Recent Developments
- 12.13 Merck Animal Health
- 12.13.1 Merck Animal Health Company Information
- 12.13.2 Merck Animal Health Business Overview
- 12.13.3 Merck Animal Health Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.13.4 Merck Animal Health Chicken Medicine and Vaccines Product Portfolio
- 12.13.5 Merck Animal Health Recent Developments
- 12.14 Harbin Veterinary Research Institute
- 12.14.1 Harbin Veterinary Research Institute Company Information
- 12.14.2 Harbin Veterinary Research Institute Business Overview
- 12.14.3 Harbin Veterinary Research Institute Revenue in Chicken Medicine and Vaccines Business (2021-2026)
- 12.14.4 Harbin Veterinary Research Institute Chicken Medicine and Vaccines Product Portfolio
- 12.14.5 Harbin Veterinary Research Institute Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst